Windlas Biotech Limited — Others, 05-07-2025: Shareholders meeting

Windlas Biotech has announced a board meeting to consider and approve the financial results for the quarter and half-year ended March 31, 2025. The company has declared a final dividend of Rs. 5.80 per equity share for FY 2024-25. Mr. Pawan Kumar Sharma is proposed for re-appointment as Executive Director. M/s J C Bhalla & Co. will replace M/s S S Kothari Mehta & Co. LLP as statutory auditors for five years with a fee of Rs. 18.5 lakh plus expenses. The remuneration of cost auditors (Rs. 60,000) for FY 2025-26 will be ratified, and M/s Sandeep Joshi & Associates appointed as secretarial auditors for five years. The Board seeks shareholder approval for ‘Windlas Plan 2025,’ an equity-based employee stock unit plan granting up to 5.9 lakh units to eligible employees and subsidiaries to attract and retain critical talent, including a proposed grant of 3.15 lakh units to CEO Komal Gupta.